Gemina Laboratories Stock Statistic Functions Linear Regression Slope

GLABF Stock

USD 0.05 0.00 0.00%

The statistic functions module provides an execution environment for Linear Regression Slope function and related indicators on Gemina Laboratories. The analysis highlights statistical functions describing dispersion and variability and frames technical signals with volatility and risk context.Please specify Time Period to execute this module.

Symbol

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Linear Regression Slope is the rate of change in Gemina Laboratories price series over its benchmark or peer price series.

Gemina Laboratories Technical Analysis Modules

Most technical analysis of Gemina Laboratories help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Gemina from various momentum indicators to cycle indicators. When you analyze Gemina charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Pink Sheet Overview, Methodology & Data Sources

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people. This stock section frames Gemina Laboratories within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 9.7. Gemina Laboratories has a market cap of 33.65 M, ROE of -3.47%.

Methodology

Unless otherwise specified, financial data for Gemina Laboratories is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Gemina (USA Stocks:GLABF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Gemina Laboratories may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Become your own money manager

Tracking Gemina Laboratories inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Dashboard Now

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Driverless Cars Invested few shares	Go
	Investor Favorites Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Blockchain Invested few shares	Go
	Social Domain Invested few shares	Go
	ESG Investing Invested few shares	Go
	Software Invested few shares	Go
	SRI Sustainable Growth Invested few shares	Go
	Impulse Invested over 200 shares	Go
	Hedge Favorites Invested few shares	Go
	Adviser Favorites Invested few shares	Go
	Artificial Intelligence Invested few shares	Go

More Resources for Gemina Pink Sheet Analysis

Other Information on Investing in Gemina Pink Sheet

Gemina Laboratories financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Gemina across valuation measures in a consistent way.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC